View By Speaker
M. Agronin, MD
M. Alexander, PhD, MA
S. Ancoli-Israel, Ph.D
L. Boesky, PhD
R. Brown, PhD
A. Burstein, MD
R. Dougherty, PhD
J. Draud, MD, MS
P. Earley
G. Emslie, MD
L. Ereshefsky, PharmD
M. Forstein, MD
A. Frances, MD
Mark Gold, MD
D. Goodman, MD
K. Gray, MD
D. Greenberg, MD
D. Greydanus, MD
R. Hendren, DO
R. Jackson, MD
R. Jain, MD, MPH
S. Jain, PsyD, LPC, MBA
J. Kane, MD
S. Katz, MSN PMH-CNS, BC
L. Kinsella, MD, FAAN
A. Krystal, MD
S. Levine, MD
J. Maldonado, MD
V. Maletic, MD, PA
B. McCarberg, MD
J. McGough, MD, MS
L. Miller, MD
L. Nagy, MD
H. Nasrallah, MD
S. Negi, MA, PhD
J. Nelson, MD
J. Newcomer, MD
G. Papakostas, MD
M. Piasecki, MD
J. Prince, MD
C. Raison, MD
P. Resnick, MD
A. Robb, MD
C. Rodgers, MD
M. Rosenberg, MD, PhD
J. Schim, MD
D. Schuyler, MD
S. Shea, MD
T. Simpatico, MD
T. Skale, MD
B. Smith, JD
T. Smith, MS Psych, PD, FASCP, LMHC, NCP
S. Sobel, MD
D. Sprague
M. Stein, MD, MPH
R. Stille, MBA
V. Strasburger, MD
J. Tsuang, MD
S. Verma, MD
J. Victoroff, MD, MA
J. Weiner, MD, PhD
S. Yaffe, MD
A. Young, MD, MSHS
|
Mark Gold, MDDistinguished Professor, Departments of Psychiatry, Neuroscience, Anesthesiology, Community Health and Family Medicine; Chairman Department of Psychiatry, Chief Division of Addiction Medicine, University of Florida
| Monday, November 2 07:45-09:00 a.m. |
113 - Globesity Crisis: Neurobiological & Addiction Perspectives & Prospects PD SC
1.25 credits - Room: Mandalay Bay Ballroom CD |
Mark Gold, MD, Distinguished Professor, Departments of Psychiatry, Neuroscience, Anesthesiology, Community Health and Family Medicine; Chairman Department of Psychiatry, Chief Division of Addiction Medicine, University of Florida
|
Tremendous progress has been made in developing animal models for addictions, new treatments based on these models and testing these in patients with drug and alcohol dependence. We will review the most current research and state-of-the-art treatment for tobacco, alcohol, and other drugs of abuse and provide a framework for understanding current progress, limitations, and hope for the future. By participating in this activity, attendees will be able to: - List major illnesses associated with obesity;
- Discuss the epidemiology of obesity and overweight; and
- Assess current theories, current treatment approaches-including minimally invasive surgery-and experimental approaches that have resulted from tests concluding that highly palatable, erotic and exotic foods act in the brain as a drug of abuse.
|
| Monday, November 2 09:15- 10:30 a.m. |
122 - Neurobiological and Addiction Perspectives and Prospects PD NP RX
1.25 credits - Room: Mandalay Bay Ballroom CD |
Mark Gold, MD, Distinguished Professor, Departments of Psychiatry, Neuroscience, Anesthesiology, Community Health and Family Medicine; Chairman Department of Psychiatry, Chief Division of Addiction Medicine, University of Florida
|
While Substance Use Disorders have been primarily thought of as those involving chemical substances like tobacco or alcohol , more recently process addictions have been studied . Once the DSM 3 diagnostic scheme was changed to accommodate cocaine and minimize withdrawal or abstinence, gambling and sexual compulsivity have been studied and suggested to be addictions. These process addictions have much neurobiology and phenomenology in common with chemical addictions and this construct may be especially helpful in understanding the obesity epidemic and logical public health and treatment approaches. Upon the completion of this activity, participants will be able to: - Review current epidemiological data on substance abuse disorders.
- Review examples of common co-occurring disorders such as tobacco smoking and alcohol and depression.
- List and Discuss diagnostic and treatment issues for co-occurring alcohol and tobacco-related illnesses.
|
|
